Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
Campo
J V
JV
Smith
C
C
Perel
J M
JM
D000293:Adolescent; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D017374:Paroxetine / Q000627:therapeutic use*; D010879:Piperazines; D016559:Tacrolimus / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D007166:Immunosuppressive Agents; D010879:Piperazines; D014230:Triazoles; D017374:Paroxetine; C051752:nefazodone; D016559:Tacrolimus